Posted on 07 February 2012
Written by Julia Kollewe for The Guardian. GlaxoSmithKline has been pulling cash out of some eurozone countries in case the debt crisis takes a turn for the worse. Speaking at the drugmaker’s annual results presentation in London, the recently knighted chief executive Sir Andrew Witty said in the past year the company had been withdrawing more »
Posted on 19 September 2014
Genmab is an internationally recognised biotechnology company developing human antibody therapeutics primarily for cancer.
Posted on 02 September 2014
By Shamini Thiagarajan Increased collaborations, big pharma involvements, venture capital investments, and medical/technological breakthroughs are together changing the landscape of research and development in orphan diseases.
Posted on 14 August 2014
By Steve Poile With 110 deals announced, the second quarter continued on from the strong start for life science M&A during 2014.
Posted on 08 June 2014
Takeda Pharmaceuticals is a top pharmaceutical company based in Osaka, Japan
Posted on 07 June 2014
Valeant Pharmaceuticals is a top pharmaceutical company based in Montreal, Quebec, Canada
Posted on 03 June 2014
With 85 deals announced, the first quarter of 2014 started strongly for life science M&A
Posted on 30 May 2014
Sanofi is a top pharmaceutical company based in Paris, France
Posted on 26 May 2014
Ranbaxy Laboratories is a top pharmaceutical company based in Haryana, India
Posted on 26 May 2014
UCB is a top pharmaceutical company based in Brussels, Belgium